Cinacalcet - et nyt medicinsk behandlingsprincip til sekundaer hyperparatyroidisme ved uraemi, parathyroideacancer og primaer hyperparatyroidisme
Engelsk titel: Cinacalcet - a new drug for the treatment of secondary hyperparathyroidism in patients with uraemia, parathyroid cancer or primary hyperparathyroidism
Läs online
Författare:
Vestergaard P
;
Rejnmark Nielsen L
;
Mosekilde L
Email: p-vest@post4.tele.dk
Språk: Dan
Antal referenser: 10
Dokumenttyp:
Översikt
UI-nummer: 06011336
Sammanfattning
Cinacalcet is a new drug with antiparathyroid effects that belongs to the class of calcimimetics. It increases the sensitivity of the calcium-sensing receptor (CaSR) to calcium, thus inducing a decrease in plasma parathyroid (PTH) levels. In patients with uncontrolled secondary hyperparathyroidism due to uremia, cinacalcet has been shown to decrease the levels of PTH even in those optimally treated with calcium and 1-ahydroxylated vitamin D. Cinacalcet decreases plasma calcium and plasma PTH levels in patients with primary hyperparathyroidism or parathyroid cancer.